UDP-ketogalactose disodium salt—a core tool molecule empowering cutting-edge glycosylation research

UDP-ketogalactose disodium salt is a key and uniquely reactive member of the sugar nucleotide family. As an important metabolic intermediate in the cellular glycosylation biosynthetic pathway, it is not only a probe for basic glycobiology research, but also a potential molecule for exploring new biosynthetic pathways and developing carbohydrate-derived therapies.

Chemical Information

Chemical name: Uridine-5'-diphosphate ketogalactose disodium salt

Common name: UDP-ketogalactose disodium salt

Chemical formula: C18H26N2O17P2Na2

Molecular weight: 650.33 g/mol

Category: Sugar Nucleotides

Structural features

UDP-ketogalactose is a structural fusion of uridine diphosphate (UDP) and a modified glycosyl moiety. It is unique in that:

Active ketone group: Compared with common UDP-galactose, the specific hydroxyl group on its galactose ring is oxidized to a ketone group. This chemical modification fundamentally changes the reactive properties of the molecule so that it no longer serves as a traditional glycosyl donor directly transferred via a glycosidic bond, but instead becomes a highly reactive electrophilic or transforming precursor.

Bifunctional module: The molecule has both the recognition and binding functions of the nucleotide moiety (usually recognized by the corresponding glycosyltransferase or synthetase), and the highly reactive carbon skeleton of the ketose moiety. This structure enables its participation in atypical enzymatic reactions or chemo-enzymatic synthesis for the construction of rare sugar derivatives or as probes for mechanistic studies.

Stable soluble salt form: The disodium salt form provides good water solubility and stability and facilitates experimental operations in biological buffer systems.

Main applications and potential

A unique tool for studying glycobiology and enzymatic mechanisms

As an oxidized derivative in the UDP-galactose metabolic pathway, UDP-ketogalactose is a key substrate or intermediate analog for studying the reaction mechanism of a series of NAD+-dependent sugar epimerases (such as UDP-galactose-4-epimerase). Its ketone structure allows researchers to capture and analyze the conformation of enzyme-substrate complexes, reveal delicate catalytic processes such as hydride transfer, reduction, and isomerization, and help elucidate the molecular basis of related genetic metabolic diseases.

Key building blocks for the synthesis of novel glycoconjugates and rare sugars

The high reactivity of the ketone group provides specific sites for chemical or enzymatic modification. Through reactions such as reductive amination, oxime bond formation, or nucleophilic addition, this molecule can be used as a starting point to synthesize a series of rare sugar nucleotide analogs that are found in natural products or drugs but are difficult to obtain. These derivatives can be used to prepare structurally novel glycoproteins, glycolipids or polysaccharide fragments to expand the chemical space of carbohydrate compounds.

Potential targets for drug discovery targeting the glycosylation pathway

Abnormal glycosylation is closely associated with cancer, inflammation, and infectious diseases. Certain pathogens or abnormal cellular metabolism may involve their specific sugar modification pathways. UDP-ketogalactose serves as a key metabolic node in the pathway, and its analogs or competitive inhibitors designed based on its structure have the potential to be developed as small molecule therapeutics for selectively interfering with the cell wall or sugar synthesis of pathogenic organisms.

Conclusion

UDP-ketogalactose disodium salt goes beyond the role of traditional sugar nucleotides as simple glycosyl donors. The reactive ketone group in its structure acts as a precise chemical handle, providing researchers with the unique ability to manipulate, track and reshape the glycosylation process. From deciphering the catalytic mysteries of fundamental life processes to providing molecular building blocks for the development of next-generation diagnostic and therapeutic strategies based on glycoscience, the value of this tool molecule is increasingly evident. A powerful and flexible chemoenzymatic synthesis platform can ensure the high purity and stable supply of such key scientific research and development raw materials, and is an important guarantee for promoting breakthroughs in related fields.

The above information is provided by the editor of KASONS and is for scientific research only.